Main trends of immune effects triggered by nanomedicines in preclinical studies
Blanka Halamoda-Kenzaoui, Susanne Bremer-Hoffmann Directorate F-Health, Consumers and Reference Materials, European Commission Joint Research Centre (JRC), Ispra (VA), Italy Abstract: The application of nanotechnology to emerging medicinal products is a crucial parameter for the implementation of...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0b56e46c056e4b8399a74ddb452bae6a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|